vs
Side-by-side financial comparison of MEDALLION FINANCIAL CORP (MFIN) and NATURES SUNSHINE PRODUCTS INC (NATR). Click either name above to swap in a different company.
NATURES SUNSHINE PRODUCTS INC is the larger business by last-quarter revenue ($123.8M vs $70.6M, roughly 1.8× MEDALLION FINANCIAL CORP). MEDALLION FINANCIAL CORP runs the higher net margin — 17.3% vs 3.3%, a 14.0% gap on every dollar of revenue. On growth, MEDALLION FINANCIAL CORP posted the faster year-over-year revenue change (25.4% vs 4.7%). Over the past eight quarters, MEDALLION FINANCIAL CORP's revenue compounded faster (15.0% CAGR vs 5.6%).
Mahindra & Mahindra Financial Services Limited (MMFSL) is an Indian rural non-banking financial company headquartered in Mumbai. It is amongst the top tractor financers in India, with 1000+ offices across the country.
Nature's Sunshine Products, Inc. also known as "NSP", is a manufacturer of dietary supplements, including herbs, vitamins, minerals, and personal care products. It is based in Lehi, Utah, with a manufacturing facility in Spanish Fork, Utah.
MFIN vs NATR — Head-to-Head
Income Statement — Q4 FY2025 vs Q4 FY2025
| Metric | | |
|---|---|---|
| Revenue | $70.6M | $123.8M |
| Net Profit | $12.2M | $4.1M |
| Gross Margin | — | 72.5% |
| Operating Margin | 29.3% | 4.3% |
| Net Margin | 17.3% | 3.3% |
| Revenue YoY | 25.4% | 4.7% |
| Net Profit YoY | 20.3% | 1379.4% |
| EPS (diluted) | $0.50 | $0.23 |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q4 25 | $70.6M | $123.8M | ||
| Q3 25 | $58.7M | $128.3M | ||
| Q2 25 | $62.6M | $114.8M | ||
| Q1 25 | $63.0M | $113.2M | ||
| Q4 24 | $56.3M | $118.2M | ||
| Q3 24 | $53.3M | $114.6M | ||
| Q2 24 | $51.0M | $110.6M | ||
| Q1 24 | $53.3M | $111.0M |
| Q4 25 | $12.2M | $4.1M | ||
| Q3 25 | $7.8M | $5.3M | ||
| Q2 25 | $11.1M | $5.3M | ||
| Q1 25 | $12.0M | $4.7M | ||
| Q4 24 | $10.1M | $-321.0K | ||
| Q3 24 | $8.6M | $4.3M | ||
| Q2 24 | $7.1M | $1.3M | ||
| Q1 24 | $10.0M | $2.3M |
| Q4 25 | — | 72.5% | ||
| Q3 25 | — | 73.3% | ||
| Q2 25 | — | 71.7% | ||
| Q1 25 | — | 72.1% | ||
| Q4 24 | — | 72.0% | ||
| Q3 24 | — | 71.3% | ||
| Q2 24 | — | 71.4% | ||
| Q1 24 | — | 71.2% |
| Q4 25 | 29.3% | 4.3% | ||
| Q3 25 | 33.2% | 7.0% | ||
| Q2 25 | 31.1% | 3.7% | ||
| Q1 25 | 32.1% | 5.4% | ||
| Q4 24 | 32.8% | 3.8% | ||
| Q3 24 | 26.6% | 4.6% | ||
| Q2 24 | 24.3% | 5.1% | ||
| Q1 24 | 33.6% | 4.2% |
| Q4 25 | 17.3% | 3.3% | ||
| Q3 25 | 13.2% | 4.2% | ||
| Q2 25 | 17.7% | 4.6% | ||
| Q1 25 | 19.1% | 4.2% | ||
| Q4 24 | 18.0% | -0.3% | ||
| Q3 24 | 16.1% | 3.8% | ||
| Q2 24 | 13.9% | 1.2% | ||
| Q1 24 | 18.8% | 2.1% |
| Q4 25 | $0.50 | $0.23 | ||
| Q3 25 | $0.32 | $0.30 | ||
| Q2 25 | $0.46 | $0.28 | ||
| Q1 25 | $0.50 | $0.25 | ||
| Q4 24 | $0.43 | $-0.02 | ||
| Q3 24 | $0.37 | $0.23 | ||
| Q2 24 | $0.30 | $0.07 | ||
| Q1 24 | $0.42 | $0.12 |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | $136.3M | $93.9M |
| Total DebtLower is stronger | $216.0M | — |
| Stockholders' EquityBook value | $408.6M | $161.6M |
| Total Assets | $3.0B | $261.1M |
| Debt / EquityLower = less leverage | 0.53× | — |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $136.3M | $93.9M | ||
| Q3 25 | $72.5M | $95.6M | ||
| Q2 25 | $110.4M | $81.3M | ||
| Q1 25 | $131.5M | $86.5M | ||
| Q4 24 | $98.2M | $84.7M | ||
| Q3 24 | $120.6M | $78.7M | ||
| Q2 24 | $87.7M | $68.7M | ||
| Q1 24 | $54.8M | $77.8M |
| Q4 25 | $216.0M | — | ||
| Q3 25 | $215.7M | — | ||
| Q2 25 | $199.9M | — | ||
| Q1 25 | $199.7M | — | ||
| Q4 24 | $232.2M | — | ||
| Q3 24 | $232.0M | — | ||
| Q2 24 | $230.8M | — | ||
| Q1 24 | $225.6M | $2.1M |
| Q4 25 | $408.6M | $161.6M | ||
| Q3 25 | $397.4M | $166.7M | ||
| Q2 25 | $389.9M | $163.7M | ||
| Q1 25 | $380.2M | $167.1M | ||
| Q4 24 | $370.2M | $161.0M | ||
| Q3 24 | $362.4M | $162.6M | ||
| Q2 24 | $354.0M | $156.4M | ||
| Q1 24 | $349.0M | $159.7M |
| Q4 25 | $3.0B | $261.1M | ||
| Q3 25 | $2.9B | $264.8M | ||
| Q2 25 | $2.9B | $254.9M | ||
| Q1 25 | $2.8B | $252.7M | ||
| Q4 24 | $2.9B | $240.9M | ||
| Q3 24 | $2.9B | $245.3M | ||
| Q2 24 | $2.8B | $235.8M | ||
| Q1 24 | $2.6B | $247.3M |
| Q4 25 | 0.53× | — | ||
| Q3 25 | 0.54× | — | ||
| Q2 25 | 0.51× | — | ||
| Q1 25 | 0.53× | — | ||
| Q4 24 | 0.63× | — | ||
| Q3 24 | 0.64× | — | ||
| Q2 24 | 0.65× | — | ||
| Q1 24 | 0.65× | 0.01× |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | $126.3M | $9.9M |
| Free Cash FlowOCF − Capex | — | $7.6M |
| FCF MarginFCF / Revenue | — | 6.1% |
| Capex IntensityCapex / Revenue | — | 1.9% |
| Cash ConversionOCF / Net Profit | 10.35× | 2.41× |
| TTM Free Cash FlowTrailing 4 quarters | — | $28.8M |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $126.3M | $9.9M | ||
| Q3 25 | $67.0M | $18.5M | ||
| Q2 25 | $-10.7M | $4.3M | ||
| Q1 25 | $36.3M | $2.6M | ||
| Q4 24 | $108.7M | $12.2M | ||
| Q3 24 | $24.6M | $9.6M | ||
| Q2 24 | $27.6M | $1.3M | ||
| Q1 24 | $32.3M | $2.2M |
| Q4 25 | — | $7.6M | ||
| Q3 25 | — | $16.8M | ||
| Q2 25 | — | $3.0M | ||
| Q1 25 | — | $1.5M | ||
| Q4 24 | — | $10.0M | ||
| Q3 24 | — | $7.9M | ||
| Q2 24 | — | $-2.0M | ||
| Q1 24 | — | $-1.5M |
| Q4 25 | — | 6.1% | ||
| Q3 25 | — | 13.1% | ||
| Q2 25 | — | 2.6% | ||
| Q1 25 | — | 1.3% | ||
| Q4 24 | — | 8.5% | ||
| Q3 24 | — | 6.9% | ||
| Q2 24 | — | -1.9% | ||
| Q1 24 | — | -1.4% |
| Q4 25 | — | 1.9% | ||
| Q3 25 | — | 1.3% | ||
| Q2 25 | — | 1.2% | ||
| Q1 25 | — | 1.0% | ||
| Q4 24 | — | 1.9% | ||
| Q3 24 | — | 1.5% | ||
| Q2 24 | — | 3.0% | ||
| Q1 24 | — | 3.3% |
| Q4 25 | 10.35× | 2.41× | ||
| Q3 25 | 8.63× | 3.46× | ||
| Q2 25 | -0.97× | 0.81× | ||
| Q1 25 | 3.02× | 0.55× | ||
| Q4 24 | 10.72× | — | ||
| Q3 24 | 2.86× | 2.21× | ||
| Q2 24 | 3.89× | 0.97× | ||
| Q1 24 | 3.22× | 0.94× |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
Revenue Breakdown by Segment
MFIN
Segment breakdown not available.
NATR
| Other | $68.1M | 55% |
| General Health Products | $20.2M | 16% |
| Digestive Products | $13.8M | 11% |
| Cardiovascular Products | $12.1M | 10% |
| Personal Care Products | $4.4M | 4% |
| Immunity Products | $3.1M | 3% |
| Weight Management Products | $2.1M | 2% |
